Shamrock Industrial Company Ltd manufactures Pharmaceuticals & Drugs products and allied business activitiesProduct Profile: Company used to manufacture API products on Contract Manufacturing basis
Shamrock Industrial Company's board approved the financial results for the quarter ended June 30, 2025, at a meeting held on August 12. The company reported zero income from operations and other revenue for the quarter. Consequently, it recorded a net loss of ₹0.116 Cr after tax. This impacts profitability, leading...
Shamrock Industrial applied to BSE for in-principle approval for a significant preferential issue. This proposed issue includes 0.59 Cr equity shares, 0.76 Cr optionally convertible debentures, and up to 0.63 Cr equity share warrants. BSE has recently provided feedback with certain observations on this application. The company is actively coordinating...
Shamrock Industrial Company Ltd has announced a certificate from its Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd., confirming that all securities received for dematerialization up to the quarter ended have been verified, mutilated, cancelled, and replaced with electronic form in the depository system. The updated securities are listed...
Date: June 24, 2025 To, BSE Ltd Corporate Relationship Dept, 1st Floor, New Trading Ring, Rotunda Building, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 BSE Scrip Code: 531240 Scrip Name: SHAMROIN Subject: Newspaper advertisement of Corrigendum to Postal ballot Notice dated May 29, 2025 pursuant to Regulation...
Shamrock Industrial Company Limited has announced a corrigendum to its Postal Ballot Notice clarifying key points related to its proposed preferential allotment of equity shares, convertible warrants, and optionally convertible debentures. The corrigendum confirms that the proposed new investors, Matador Technologies Inc. and Mr. Bal Kishan Gupta, will remain non-promoters...
